Fulgent Genetics Inc. Revenue 2014–2025
Fulgent Genetics Inc. annual/quarterly revenue history and growth rate from 2014 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Fulgent Genetics Inc. revenue for the quarter ending March 31, 2026 was 71.1 M, a 3.16% decrease year-over-year.
- Fulgent Genetics Inc. revenue for the twelve months ending March 31, 2026 was 310.5 M, a 6.35% increase year-over-year.
- Fulgent Genetics Inc. annual revenue for 2025 was 322.7 M, a 13.83% increase from 2024.
- Fulgent Genetics Inc. annual revenue for 2024 was 283.5 M, a 1.99% decrease from 2023.
- Fulgent Genetics Inc. annual revenue for 2023 was 289.2 M, a 53.27% decrease from 2022.
- Fulgent Genetics Inc. annual revenue for 2022 was 619.0 M.
Fulgent Genetics Inc. (FLGT) — Frequently Asked Questions
Fulgent Genetics Inc. (FLGT) is a publicly traded US company. It has a market capitalization of $583M. In fiscal 2025 it reported revenue of $323M and net income of -$61M. Explore FLGT's stock price, financial statements, earnings history, margins and key ratios below.
What is Fulgent Genetics Inc.'s market cap?
Fulgent Genetics Inc. (FLGT) has a market capitalization of $583M.
What is the FLGT stock price?
FLGT trades at $18.93 (+2.32% on the day).
How much revenue does Fulgent Genetics Inc. make?
Fulgent Genetics Inc. reported revenue of $323M in fiscal 2025.
Is FLGT profitable?
In fiscal 2025, Fulgent Genetics Inc. reported net income of -$61M.